Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366757617> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4366757617 endingPage "293" @default.
- W4366757617 startingPage "284" @default.
- W4366757617 abstract "In this work, an RP-HPLC method was established for the simultaneous quantification of antazoline sulfate and naphazoline nitrate in commercial ophthalmic formulations. The proposed method was validated for sensitivity, selectivity, linearity, accuracy, precision, and stability, and was found to be suitable for routine analysis of these two active ingredients in the presence of degradation products. The optimized conditions using a C18 column, a mobile phase (phosphate buffer: methanol, 80:20), a flow rate of 1.5 mL/min, and detection at 285 nm at room temperature. The quantification method for antazoline sulfate and naphazoline nitrate in the pharmaceutical formulation was validated in accordance with International Conference on Harmonization (ICH) Q2 (R1) guidelines for the quantitative measurement of these pharmaceuticals. Under optimal conditions, a linear relationship with high correlation coefficients (0.9999 for Antazoline Sulfate and 0.9997 for Naphazoline Nitrate) was established between the concentration ranges of 0.11 to 0.35 mg/mL for Antazoline sulfate and 0.006–0.02 mg/mL for Naphazoline nitrate. The detection limits of Antazoline sulfate and Naphazoline nitrate were determined to be 0.3 and 0.06 μg/mL, respectively. The developed method can be useful for quality control and stability testing of ophthalmic formulations containing antazoline nitrate and naphazoline sulfate." @default.
- W4366757617 created "2023-04-24" @default.
- W4366757617 creator A5011196405 @default.
- W4366757617 creator A5012657474 @default.
- W4366757617 creator A5064923569 @default.
- W4366757617 creator A5089924554 @default.
- W4366757617 date "2022-12-14" @default.
- W4366757617 modified "2023-10-03" @default.
- W4366757617 title "Development of a stability-indicating HPLC method for the simultaneous quantification of antazoline nitrate and naphazoline sulfate in a commercial ophthalmic formulation" @default.
- W4366757617 cites W154030139 @default.
- W4366757617 cites W1969015655 @default.
- W4366757617 cites W1998354752 @default.
- W4366757617 cites W2030073021 @default.
- W4366757617 cites W2040457412 @default.
- W4366757617 cites W2050536044 @default.
- W4366757617 cites W2061297412 @default.
- W4366757617 cites W2062345527 @default.
- W4366757617 cites W2064308895 @default.
- W4366757617 cites W2093259357 @default.
- W4366757617 cites W2147185632 @default.
- W4366757617 cites W2531914978 @default.
- W4366757617 cites W4226082735 @default.
- W4366757617 doi "https://doi.org/10.1080/10826076.2023.2202220" @default.
- W4366757617 hasPublicationYear "2022" @default.
- W4366757617 type Work @default.
- W4366757617 citedByCount "1" @default.
- W4366757617 countsByYear W43667576172023 @default.
- W4366757617 crossrefType "journal-article" @default.
- W4366757617 hasAuthorship W4366757617A5011196405 @default.
- W4366757617 hasAuthorship W4366757617A5012657474 @default.
- W4366757617 hasAuthorship W4366757617A5064923569 @default.
- W4366757617 hasAuthorship W4366757617A5089924554 @default.
- W4366757617 hasConcept C106186310 @default.
- W4366757617 hasConcept C178790620 @default.
- W4366757617 hasConcept C179998833 @default.
- W4366757617 hasConcept C185592680 @default.
- W4366757617 hasConcept C2778343803 @default.
- W4366757617 hasConcept C43617362 @default.
- W4366757617 hasConcept C45904493 @default.
- W4366757617 hasConcept C71924100 @default.
- W4366757617 hasConcept C98274493 @default.
- W4366757617 hasConceptScore W4366757617C106186310 @default.
- W4366757617 hasConceptScore W4366757617C178790620 @default.
- W4366757617 hasConceptScore W4366757617C179998833 @default.
- W4366757617 hasConceptScore W4366757617C185592680 @default.
- W4366757617 hasConceptScore W4366757617C2778343803 @default.
- W4366757617 hasConceptScore W4366757617C43617362 @default.
- W4366757617 hasConceptScore W4366757617C45904493 @default.
- W4366757617 hasConceptScore W4366757617C71924100 @default.
- W4366757617 hasConceptScore W4366757617C98274493 @default.
- W4366757617 hasIssue "17-20" @default.
- W4366757617 hasLocation W43667576171 @default.
- W4366757617 hasOpenAccess W4366757617 @default.
- W4366757617 hasPrimaryLocation W43667576171 @default.
- W4366757617 hasRelatedWork W1977798251 @default.
- W4366757617 hasRelatedWork W1995604348 @default.
- W4366757617 hasRelatedWork W2046024352 @default.
- W4366757617 hasRelatedWork W2055781229 @default.
- W4366757617 hasRelatedWork W2145213465 @default.
- W4366757617 hasRelatedWork W2189200885 @default.
- W4366757617 hasRelatedWork W2313641457 @default.
- W4366757617 hasRelatedWork W2405302437 @default.
- W4366757617 hasRelatedWork W2417209194 @default.
- W4366757617 hasRelatedWork W3200692342 @default.
- W4366757617 hasVolume "45" @default.
- W4366757617 isParatext "false" @default.
- W4366757617 isRetracted "false" @default.
- W4366757617 workType "article" @default.